[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Pages 60500-60501]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-23829]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: R & D Systems, 
Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: R & D Systems, Inc., applied to be registered as an importer 
of certain basic classes of controlled substances. The DEA grants R & D 
Systems, Inc., registration as an importer of those controlled 
substances.

SUPPLEMENTARY INFORMATION: By notice dated May 28, 2014, and published 
in the Federal Register on June 4, 2014, FR 79 32318, R & D Systems, 
Inc., 614 McKinley Place NE., Minneapolis, Minnesota 55413, applied to 
be registered as an importer of certain basic classes of controlled 
substances. No comments or objections were submitted for this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of R & D Systems, Inc., to import the basic classes of 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by: Inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance

[[Page 60501]]

with 21 CFR 1301.34, the above-named company is granted registration as 
an importer of the basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N-methylcathinone)      I
 (1248).
1-Pentyl-3-(1-naphthoyl)indole) (7118).....  I
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-         I
 hydroxycyclohexyl-phenol) (7297).
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
4-Bromo-2,5-dimethoxyamphetamine (7391)....  I
3,4-Methylenedioxymethamphetamine (7405)...  I
Dimethyltryptamine (7435)..................  I
Psilocyn (7438)............................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Pentobarbital (2270).......................  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Oxycodone (9143)...........................  II
Thebaine (9333)............................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances in 
dosage form to distribute to researchers.
    In reference to drug codes 7360 and 7370, the company plans to 
import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No 
other activity for these drug codes is authorized for this 
registration.
    The import of the above listed basic classes of controlled 
substances would be granted only for analytical testing and clinical 
trials. This authorization does not extend to the import of a finished 
Food and Drug Administration approved or non-approved dosage form for 
commercial distribution in the United States.

    Dated: September 26, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-23829 Filed 10-6-14; 8:45 am]
BILLING CODE 4410-09-P